Bifogade filer
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Lifecare ASA via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
Land | Norge |
---|---|
Lista | Oslo Bors |
Sektor | Hälsovård |
Industri | Medicinteknik |
2024-06-13 14:33:00
Bergen, Norway, June 13th, 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that the company has concluded a successful in-vitro quality test of sensor for use in longevity study.
Reference is made to stock exchange notification June 10th, 2024. The internal in-vitro quality test has been successfully conducted.